BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34025450)

  • 1. Adrenaline May Contribute to Prothrombotic Condition via Augmentation of Platelet Procoagulant Response, Enhancement of Fibrin Formation, and Attenuation of Fibrinolysis.
    Golaszewska A; Misztal T; Marcinczyk N; Chabielska E; Rusak T
    Front Physiol; 2021; 12():657881. PubMed ID: 34025450
    [No Abstract]   [Full Text] [Related]  

  • 2. The myeloperoxidase product, hypochlorous acid, reduces thrombus formation under flow and attenuates clot retraction and fibrinolysis in human blood.
    Misztal T; Golaszewska A; Tomasiak-Lozowska MM; Iwanicka M; Marcinczyk N; Leszczynska A; Chabielska E; Rusak T
    Free Radic Biol Med; 2019 Sep; 141():426-437. PubMed ID: 31279970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxynitrite may affect fibrinolysis via the reduction of platelet-related fibrinolysis resistance and alteration of clot structure.
    Misztal T; Rusak T; Brańska-Januszewska J; Ostrowska H; Tomasiak M
    Free Radic Biol Med; 2015 Dec; 89():533-47. PubMed ID: 26454084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HAuCl
    Misztal T; Golaszewska A; Branska-Januszewska J; Marcinczyk N; Chabielska E; Tomasiak M; Rusak T
    Front Physiol; 2020; 11():1025. PubMed ID: 32973556
    [No Abstract]   [Full Text] [Related]  

  • 5. Study on the Mechanism of the Adrenaline-Evoked Procoagulant Response in Human Platelets.
    Gołaszewska A; Misztal T; Kazberuk A; Rusak T
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood clot contraction differentially modulates internal and external fibrinolysis.
    Tutwiler V; Peshkova AD; Le Minh G; Zaitsev S; Litvinov RI; Cines DB; Weisel JW
    J Thromb Haemost; 2019 Feb; 17(2):361-370. PubMed ID: 30582674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of c7E3 Fab on thrombus formation and rt-PA-Mediated thrombolysis under flow conditions.
    Huang TC; Jordan RE; Hantgan RR; Alevriadou BR
    Thromb Res; 2001 Jun; 102(5):411-25. PubMed ID: 11395127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of collagen-adherent platelets in mediating fibrin formation in flowing whole blood.
    Kirchhofer D; Tschopp TB; Steiner B; Baumgartner HR
    Blood; 1995 Nov; 86(10):3815-22. PubMed ID: 7579349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The procoagulant effect of thrombin on fibrin(ogen)-bound platelets.
    Sanders MW; Nieuwenhuys CM; Feijge MA; Rook M; Béguin S; Heemskerk JW
    Haemostasis; 1998; 28(6):289-300. PubMed ID: 10461011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen associates with phosphatidylserine-exposing platelets and contributes to thrombus lysis under flow.
    Whyte CS; Swieringa F; Mastenbroek TG; Lionikiene AS; Lancé MD; van der Meijden PE; Heemskerk JW; Mutch NJ
    Blood; 2015 Apr; 125(16):2568-78. PubMed ID: 25712989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ClfA(221-550), a fibrinogen-binding segment of Staphylococcus aureus clumping factor A, disrupts fibrinogen function.
    Liu CZ; Shih MH; Tsai PJ
    Thromb Haemost; 2005 Aug; 94(2):286-94. PubMed ID: 16113817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-related fibrinolysis resistance in patients suffering from PV. Impact of clot retraction and isovolemic erythrocytapheresis.
    Rusak T; Piszcz J; Misztal T; Brańska-Januszewska J; Tomasiak M
    Thromb Res; 2014 Jul; 134(1):192-8. PubMed ID: 24824295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombus formation with rehydrated, lyophilized platelets.
    Fischer TH; Merricks EP; Bode AP; Bellinger DA; Russell K; Reddick R; Sanders WE; Nichols TC; Read MS
    Hematology; 2002 Dec; 7(6):359-69. PubMed ID: 12475741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clot retraction facilitates clot lysis.
    Carroll RC; Gerrard JM; Gilliam JM
    Blood; 1981 Jan; 57(1):44-8. PubMed ID: 7448414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ionic and nonionic contrast media on clot structure, platelet function and thrombolysis mediated by tissue plasminogen activator in plasma clots.
    Carr ME; Carr SL; Merten SR
    Haemostasis; 1995; 25(4):172-81. PubMed ID: 7557656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A structural and dynamic investigation of the facilitating effect of glycoprotein IIb/IIIa inhibitors in dissolving platelet-rich clots.
    Collet JP; Montalescot G; Lesty C; Weisel JW
    Circ Res; 2002 Mar; 90(4):428-34. PubMed ID: 11884372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procoagulant activity on platelets adhered to collagen or plasma clot.
    Ilveskero S; Siljander P; Lassila R
    Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):628-35. PubMed ID: 11304482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into platelet-based control of coagulation.
    de Witt SM; Verdoold R; Cosemans JM; Heemskerk JW
    Thromb Res; 2014 May; 133 Suppl 2():S139-48. PubMed ID: 24862135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MASP-1 of the complement system alters fibrinolytic behaviour of blood clots.
    Jenny L; Noser D; Larsen JB; Dobó J; Gál P; Pál G; Schroeder V
    Mol Immunol; 2019 Oct; 114():1-9. PubMed ID: 31325724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.